Increasing halitosis disease burden across the globe is expected to boost industry growth.

According to a new report by Reports and Data, the Global Halitosis Treatment Market size was valued at USD 10.75 Billion in 2020 and is forecast to exceed USD 28.53 Billion in terms of revenue, at a CAGR of 13.1% through 2028. The market growth is driven by increased consumption of tobacco products and rising prevalence of periodontal diseases across the globe.

Halitosis is a condition of bad breath arising due to one of the many factors, including bad oral hygiene, side-effect of medications, alcohol consumption, smoking, crash diets, diabetes, GERD, lactose intolerance, and gum diseases, and others. It is a clinical condition that generally leads to social restraints.

The condition has become a major issue across the globe where a moderate case of halitosis is quite high, severe cases are limited to 5% of the population only. In the US, approximately 80 million people spend more than USD 10.75 Billion annually on oral hygiene products. Rising prevalence of halitosis coupled with increasing awareness regarding the disease and its treatment will foster halitosis market size through 2028.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1469

The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.

The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.

Key companies profiled in the report include:

Colgate-Palmolive Company, Dr. Harold Katz, LLC, All USA Partners LLC., Rowpar Pharmaceuticals, Inc., Listerine, Abbott, AstraZeneca, Novartis, Oral B, GSK, Philips Oral Healthcare, Pfizer, and Roche among others.

Market Segmentation by Types:

Type Outlook (Revenue, USD Billion; 2020-2028)

  • Pathological
  • Non-Pathological

Indication Outlook (Revenue, USD Billion; 2020-2028)

  • Lungs
  • Liver
  • Respiratory
  • Systemic
  • Gastrointestinal
  • Others

Diagnostic Tests Outlook (Revenue, USD Billion; 2020-2028)

  • Gas Chromatography
  • Halimeter
  • Beta-galactosidase activity assay
  • Others

Drug Treatment Outlook (Revenue, USD Billion; 2020-2028)

  • Antiseptic
  • Antacids
  • Ranitidine
  • Other

End Users Outlook (Revenue, USD Billion; 2020-2028)

  • Hospitals
  • Clinics

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1469

Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Halitosis Treatment market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/halitosis-treatment-market

Further key findings from the report suggest

  • Based on type, the pathological segment accounted for 53% of the market share in 2020 and is forecast to contribute significantly to the revenue share through 2028. Pathological treatment includes a number of medical specialties that diagnose diseases with the analysis of tissue, cell, and body fluid samples. Accuracy of these tests is the key factor boosting segmental growth.
  • Based on indication, the liver segment is projected to have the highest CAGR of 13.9% over the analysis period. This can be attributed to rising cases of ‘Frank liver failure’ and ‘late stage liver failure’, and both of these lead to bad breath problem.
  • Based on drug treatment type, the antacid segment is estimated to deliver a CAGR of 13.7% through 2028. Antacids are in high demand owing to its ability to neutralize stomach acid and relieve indigestion, which effectively helps in limiting bad breath.
  • Based on end-use, the hospitals segment accounted for 48% of the market share in 2020 and is forecast to deliver significant growth through 2028. This can be attributed to increased extreme cases of halitosis being recorded in hospital settings over the past few years. Generally, people do not treat bad breath unless it becomes a serious social problem.
  • Geographically, North America accounted for 31% of the halitosis market share in 2020 and is forecast to observe major traction through 2028 on account of rising awareness among populace regarding the disease and availability of its treatment is in the region.
  • Asia Pacific is estimated to deliver highest growth rate during the forecast period on account of increasing awareness regarding diagnosis methods and treatment for halitosis among masses. In addition, surging cases of chronic diseases such as respiratory diseases, diabetes, lungs or liver failure, and others will positively impact regional industry growth in the coming years.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1469

Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.

Browse More Reports:

Self-Sampling Blood Collection and Storage Devices Market  @ https://www.reportsanddata.com/report-detail/self-sampling-blood-collection-and-storage-devices-market

Biosurgery Market @ https://www.reportsanddata.com/report-detail/biosurgery-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                                        

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com